MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.730
-0.020 (-1.14%)
Feb 24, 2026, 4:00 PM EST - Market closed

MacroGenics Revenue

MacroGenics had revenue of $72.84M in the quarter ending September 30, 2025, a decrease of -34.21%. This brings the company's revenue in the last twelve months to $127.63M, down -9.70% year-over-year. In the year 2024, MacroGenics had annual revenue of $149.96M with 155.26% growth.

Revenue (ttm)
$127.63M
Revenue Growth
-9.70%
P/S Ratio
0.86
Revenue / Employee
$374,270
Employees
341
Market Cap
109.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024149.96M91.21M155.26%
Dec 31, 202358.75M-93.19M-61.33%
Dec 31, 2022151.94M74.49M96.19%
Dec 31, 202177.45M-27.44M-26.16%
Dec 31, 2020104.88M40.70M63.40%
Dec 31, 201964.19M4.07M6.76%
Dec 31, 201860.12M-97.62M-61.89%
Dec 31, 2017157.74M65.86M71.68%
Dec 31, 201691.88M-8.97M-8.90%
Dec 31, 2015100.85M53.06M111.00%
Dec 31, 201447.80M-10.24M-17.64%
Dec 31, 201358.04M-5.79M-9.07%
Dec 31, 201263.83M6.62M11.57%
Dec 31, 201157.21M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Agenus106.83M
Fortress Biotech62.30M
Codexis52.93M
Seer, Inc.16.38M
Korro Bio7.37M
Equillium4.39M
Coya Therapeutics3.99M
Cardiff Oncology501.00K
Revenue Rankings